Injury Type-Specific Calcium Channel 2-1 Subunit Up- Regulation in Rat Neuropathic Pain Models Correlates with Antiallodynic Effects of Gabapentin

Transcription

1 /02/ $7.00 THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS Vol. 303, No. 3 Copyright 2002 by The American Society for Pharmacology and Experimental Therapeutics 41574/ JPET 303: , 2002 Printed in U.S.A. Injury Type-Specific Calcium Channel 2-1 Subunit Up- Regulation in Rat Neuropathic Pain Models Correlates with Antiallodynic Effects of Gabapentin Z. D. LUO, N. A. CALCUTT, E. S. HIGUERA, C. R. VALDER, Y.-H. SONG, C. I. SVENSSON, and R. R. MYERS Departments of Anesthesiology (Z.D.L., E.S.H., C.R.V., Y.-H.S., C.I.S., R.R.M.), Pathology (N.A.C., R.R.M.), and Chemistry/Biochemistry (C.R.V.), University of California San Diego, La Jolla, California Received July 11, 2002; accepted August 22, 2002 ABSTRACT The calcium channel 2-1 subunit is a structural subunit important for functional calcium channel assembly. In vitro studies have shown that this subunit is the binding site for gabapentin, an anticonvulsant that exerts antihyperalgesic effects by unknown mechanisms. Increased expression of this subunit in the spinal cord and dorsal root ganglia (DRG) has been suggested to play a role in enhanced nociceptive responses of spinal nerve-injured rats to innocuous mechanical stimulation (allodynia). To investigate whether a common mechanism underlies allodynic states derived from different etiologies, and if so, whether similar 2-1 subunit up-regulation correlates with these allodynic states, we compared DRG and spinal cord 2-1 subunit levels and gabapentin sensitivity in allodynic rats Peripheral nerve injury can lead to a neuropathic pain state, termed tactile allodynia, in which innocuous tactile stimulation elicits pain behavior. Spinal administration of gabapentin, a novel anticonvulsant that binds to the 2 subunits of the voltage-gated calcium channels in vitro (Marais et al., 2001), suppresses allodynia in neuropathic pain models without general analgesic effects (Hwang and Yaksh, 1997; Abdi et al., 1998; Field et al., 1999). In addition, the potencies of gabapentinoids against neuropathic pain correlate with their sterospecificity and binding affinities at the 2 site (Suman-Chauhan et al., 1993; Dissanayake et al., 1997; Hwang and Yaksh, 1997). These observations have led to the hypothesis that nerve injury may cause changes in spinal 2 subunit expression, which in turn results in an This study was supported in part by an institutional grant from Howard Hughes Medical Institute (to Z.D.L.) and by National Institutes of Health Grants DE-13270, NS (to Z.D.L.), NS (to N.A.C.), and NS (R.R.M.). Data from this study were presented as an abstract form in the 10th World Congress on Pain of International Association for the Study of Pain. Article, publication date, and citation information can be found at DOI: /jpet with mechanical nerve injuries (sciatic nerve chronic constriction injury, spinal nerve transection, or ligation), a metabolic disorder (diabetes), or chemical neuropathy (vincristine neurotoxicity). Our data indicated that even though allodynia occurred in all types of nerve injury investigated, DRG and/or spinal cord 2-1 subunit up-regulation and gabapentin sensitivity only coexisted in the mechanical and diabetic neuropathies. Thus, induction of the 2-1 subunit in the DRG and spinal cord is likely regulated by factors that are specific for individual neuropathies and may contribute to gabapentin-sensitive allodynia. However, the calcium channel 2-1 subunit is not the sole molecular change that uniformly characterizes the neuropathic pain states. enhanced neuronal excitability that contributes to neuropathic pain development. The 2 subunit is important for functional assembly of the voltage-gated calcium channels. It is a glycoprotein consisting of covalently linked 2 - and -peptides that are encoded by the same gene (De Jongh et al., 1990). Except for a single transmembrane domain and five C-terminal amino acids, the majority of the 2 subunit is extracellular. In vitro studies have indicated that the extracellular domain of the subunit is important for channel function and coexpression of the 2 subunit with other calcium channel subunits results in enhanced calcium channel currents. This is accompanied by an increase in both the number of binding sites and their affinity for -conotoxin, a ligand for neuronal voltage-gated calcium channels (Mori et al., 1991; Williams et al., 1992; Brust et al., 1993; Gurnett et al., 1996). Three genes have been identified in mice that encode the 2-1, 2-2, and 2-3 subunits, respectively (Klugbauer et al., 1999). The tissue-specific expression patterns of these subunits suggest that they may have diversified functions (Marais et al., 2001), and recent studies have suggested that the three 2 subunits may contribute differentially to sensory information processing. ABBREVIATIONS: DRG, dorsal root ganglia; SNL, spinal nerve ligation; SNTx, spinal nerve transection; CCI, sciatic nerve chronic constriction injury; DB, diabetes; VIN, vincristine; HEK, human embryonic kidney; PWT, paw withdrawal threshold. 1199

2 1200 Luo et al. In situ studies have shown that mrna for the 2-1 and 2-2 subunits is expressed at high levels in small dorsal root ganglion (DRG) sensory neurons and at lower levels in large DRG neurons. Conversely, mrna for the 2-3 is relatively abundant in large DRG neurons and scarce in small sensory neurons (Yusaf et al., 2001b). Binding studies have shown that the 2-1 and 2-2, but not the 2-3, subunits bind gabapentin with high affinities (Marais et al., 2001). We have recently observed a marked up-regulation of the 2-1 subunit in rat DRG that correlated tightly with gabapentin-sensitive tactile allodynia after spinal nerve ligation (Luo et al., 2001). This prompted the speculation that the 2-1 subunit may play a role in gabapentin-sensitive tactile allodynia. However, tactile allodynia may be induced by a variety of nerve lesions, and it is not clear that these findings can be extrapolated to all nerve injury states that exhibit tactile allodynia. Indeed, data from clinical investigations have indicated that gabapentin sensitivity varies in neuropathic pain states arising from different types of nerve injury, suggesting that the mechanisms underlying the action of gabapentin in pain states of differing etiology may vary (Laird and Gidal, 2000). As a first step toward uncovering the potential role of the 2-1 subunit in neuropathic pain, we investigated whether increased 2-1 subunit expression is common to a range of nerve injury models that display tactile allodynia. We examined levels of the 2-1 subunit in both the DRG and spinal cord of rats with mechanical injuries induced by spinal nerve ligation (SNL), spinal nerve transection (SNTx), or sciatic nerve chronic constriction injury (CCI), with a metabolic neuropathy induced by diabetes (DB) and with a toxic neuropathy induced by vincristine (VIN). In addition, we compared gabapentin sensitivity in these models and correlate that with the spinal cord and DRG 2-1 subunit expression. Materials and Methods Materials. The monoclonal antibody raised against a human neuronal 2 peptide and its positive controls were derived from membrane extracts of human embryonic kidney (HEK) 293 cells overexpressing the human 2 b cdnas and were provided by Merck Neuroscience Research Laboratories (La Jolla, CA). This antibody has been shown to specifically interact with the rat 2 subunit (Luo et al., 2001). Tris-acetate gels (NuPAGE) and buffers were obtained from Invitrogen (Carlsbad, CA). Horseradish peroxidase-labeled secondary antibodies (mouse IgG) and their substrates and enhancer solutions were from Pierce Chemical (Rockford, IL). The ECF Western blotting kit was from Amersham Biosciences UK, Ltd. (Little Chalfont, Buckinghamshire, UK). Gabapentin was from Parke-Davis Pharmaceuticals (Ann Arbor, MI). Other chemicals were from Sigma-Aldrich (St. Louis, MO). Animals. Rats (Sprague-Dawley; Harlan, Indianapolis, IN) were housed in separate cages and exposed to a 12-h day/night cycle with free access to food and water. All animal care and experiments were carried out according to protocols approved by the Institutional Animal Care Committee of the University of California, San Diego. Neuropathic Lesions and Drug Administration. Spinal nerve ligation was induced by the procedure described by Kim and Chung (1992). Briefly, the left L5/6 lumbar spinal nerves of male Harlan rats ( g) were exposed in halothane/oxygen-anesthetized rats and tightly ligated with 6.0 silk suture between their DRGs and the conjunction to form the sciatic nerve. Spinal nerve transection was performed at a similar location. Sham operations were performed in the same way except that spinal nerves were not ligated or transected. Chronic constriction injury of the sciatic nerve was performed as described by Bennett and Xie (1988). Briefly, four loose ligatures with about 1-mm spacing were placed around the left sciatic nerve at the mid-thigh level of anesthetized Harlan rats ( g). The sciatic nerve was exposed but not ligated in sham control rats. Diabetic neuropathy was induced by a single intraperitoneal injection of 50 mg/kg streptozotocin to ablate pancreatic cells and induce insulin deficiency. Noninjected, age-matched rats were used as controls. Diabetes was confirmed in these rats 2 days later by measuring blood glucose concentrations. Only animals with a blood glucose concentration above 15 mm were included as diabetic. Hyperglycemia ( mm in diabetic rats, mm in control rats, n 5) and allodynia [50% paw withdrawal threshold (PWT): g in diabetic rats, g in control rats, n 5; Fig. 1D] were confirmed at the time of tissue collections. Vincristine-induced neuropathy was induced as described previously (Nozaki-Taguchi et al., 2001). Because this model mimics the dose-limiting side effects of vincristine in human patients, Harlan rats with a larger body weight ( g) were used to reduce the mortality of vincristine treatment (Nozaki-Taguchi et al., 2001). Briefly, the pumps filled with the drug solutions or sterile saline alone were primed at 37 C for 4 h before surgery. Catheters (polyethylene-60 tubing) were inserted into an external jugular vein of anesthetized rats and tunneled subcutaneously. The catheter was linked to an osmotic pump (Alzet model 2002; Alza, Newark, DE) that was pocketed subcutaneously into the posterior thoracic area. All incisions were closed with 4.0 silk suture. Vincristine (30 g/kg/ day in sterile saline or saline alone) was infused continuously for 2 weeks through the intravenous miniosmotic pump. Gabapentin was dissolved in sterile saline and injected intraperitoneally (1-ml total volume) at designated times. The same volume of saline was injected into control rats. Behavioral Testing. Tactile allodynia was tested as described previously (Chaplan et al., 1994). Briefly, after 15 min of acclimation, rats in a clear plastic cage with a wire mesh bottom were tested for the 50% PWT to von Frey filaments (Stoelting, Wood Dale, IL) using a modified up-down method of Dixon (1980). A filament with a calibrated 2.0-g buckling weight was applied to the left hindpaw plantar surface with a pressure causing the filament to bend. Absence of a paw lifting after 5 s led to the use of the next filament with increasing weight, and paw lifting indicated a positive response and led to the use of the next weaker filament. This paradigm continued until a total of six measurements, including the one before the first paw-lifting response had been made, or until four consecutive positive (assigned a score of 0.25 g) or five consecutive negative (assigned a score of 15 g) responses had occurred. The 50% response threshold was then calculated from the resulting scores as described previously (Luo et al., 2001). Western Blot. Frozen tissue was pulverized and extracted in 50 mm Tris buffer, ph 8.0, containing 0.5% Triton, 150 mm NaCl, 1 mm EDTA, and protease inhibitors, and the cell extracts applied to electrophoresis in NuPAGE Tris-acetate gels under reducing conditions (0.05 M dithiothreitol) then electrophoretically transferred to nitrocellulose membranes (Schleicher & Schuell, Keene, NH). The 2 monoclonal antibodies in phosphate-buffered saline containing 0.1% Tween 20 were incubated with the membranes for 1 h at room temperature or overnight at 4 C after nonspecific binding sites were blocked with 5% low-fat milk. The antibody-protein complexes were detected by incubating the membrane with secondary antibodies labeled either with horseradish peroxidase or fluorescein for 1 h at room temperature followed by washing and addition of chemiluminescent reagents or of antifluorescein antibody and ECF substrate, respectively. Extracts of HEK293 cell membranes overexpressing the human neuronal 2-1 gene were used as positive controls. Under reducing conditions, the -peptide separates from the 2 subunit (Jay et al., 1991) so the positive bands detected by the primary antibody reflect the 2 subunit only. Signal intensities were quantified by either densitometry within the linear range of the film sen-

3 Injury Type-Specific Ca 2 Channel 2-1 Subunit Regulation 1201 sitivity curve or a fluorescence scanning system (Storm; Molecular Dynamics, Sunnyvale, CA). Statistical Analyses. Data were reported as means S.E.M. Unpaired Student s t tests were performed where significance was indicated by two-tailed p values: *p 0.05, **p 0.01, and ***p Fig. 1. Representative Western blots showing 2-1 subunit expression in dorsal spinal cord and DRG of rat neuropathic models and the allodynic states associated with these models at the times of tissue harvesting. Western blot analyses, as described under Materials and Methods, were performed on protein extracts of frozen dorsal spinal cord and DRG samples collected from Sprague-Dawley rats 1 week after SNL or SNTx, CCI of the sciatic nerve, or 4 weeks after the beginning of DB induction or VIN treatment. A C, representative data from rats with mechanical, diabetes-, or vincristine-induced nerve injuries, respectively. Each blot represents the results from at least three independent experiments in each group. Membrane extracts of HEK cells overexpressing human 2 b -1 subunit were used as positive controls shown as 2 bands because the -peptide was separated from the 2 subunit under denaturing conditions. S.C., spinal cord; C, contralateral or control; Ip, ipsilateral; D, diabetic; V, vincristine-treated. D, summarized PWTs to von Frey filament stimulation in sham (SNL, SNTx, and CCI)/control (DB and VIN) and injured animals at time points of tissue collection for Western blot analyses. The same sham controls were used for SNL and SNTx groups because the surgery procedures were almost identical except for the steps of nerve ligation or transection. Numbers in the parentheses represent the numbers of animals used in each group. The asterisks indicate significant changes compared with the control values (, p 0.001) as determined by unpaired two-tailed Student s t test. Results Up-Regulation of DRG and/or Spinal Cord 2-1 Subunit Was Induced by Mechanical and Diabetes-, but Not Vincristine-Induced, Neuropathies. Our previous experiments have shown up-regulation of the 2-1 subunit in DRG and spinal cord of rats with spinal nerve ligation injuries (Luo et al., 2001). To test whether DRG and spinal cord 2-1 subunit up-regulation also occurs in other neuropathic pain models manifesting similar allodynic states, we compared 2-1 subunit levels in DRG and dorsal spinal cord of rats with neuropathies derived from SNL, SNTx, CCI, DB, and VIN. The time points chosen in each category (1 week after mechanical injuries, 4 weeks after the initiation of diabetes and vintristine treatment) corresponded to times when significant tactile allodynia occurs in these neuropathic rats as shown in Fig. 1D. Our Western blot data indicated that only the mechanical peripheral nerve injuries caused significant 2-1 subunit up-regulation in DRG ipsilateral to the injury compared with that in DRG from the contralateral side and sham-operated rats. The degree of DRG 2-1 upregulation seemed to correlate with the severity of the injuries because that induced by CCI was much less than that induced by SNL and SNTx (Figs. 1A and 2A). DRG 2-1 subunit expression in DB and VIN rats was not significantly increased compared with levels in DRG of matched control rats (Figs. 1, B and C, and 2A). In dorsal spinal cord, only SNL and DB caused a significant increase in 2-1 subunit expression compared with that in sham and control rats, respectively (Fig. 1, A and B, and 2B). A summary of Western blot data is included in Table 1. The variation in DRG 2-1 subunit up-regulation after different mechanical injuries could reflect either the severity of the injury or different distances between the injury sites to DRG. To explore these possibilities, we examined the timedependent regulation of DRG 2-1 subunit in the SNL and CCI models, the former often causes more severe damage to peripheral axons and has a closer injury site to the DRG than the latter. As indicated in Fig. 3, DRG 2-1 subunit levels were increased 15-fold 4 days after SNL, which is before the peak of allodynia (Luo et al., 2001) and remained at the same level for 2 weeks after the injury. In contrast, DRG 2-1 subunit expression was increased less than 5-fold 4 days after CCI and remained at the same level 2 weeks after the injury when allodynia was fully developed. Development of Tactile Allodynia and Its Gabapentin Sensitivity in Neuropathic Pain Models. All neuropathic models developed tactile allodynia at the time of tissue harvesting (Fig. 1D) and before gabapentin treatment (Fig. 4; Table 1). To examine whether antiallodynic effects of gabapentin correlate with expression levels of spinal cord and DRG 2-1 subunit in these neuropathic models, we compared the effects of 50 mg/kg intraperitoneal gabapentin on fully developed tactile allodynia in these models. The gabapentin treatment resulted in similar therapeutic profiles in all the ani-

4 1202 Luo et al. Fig. 2. Summarized 2-1 subunit levels in DRG and dorsal spinal cord of rats with different neuropathies. A and B, 2-1 protein levels in DRG and dorsal spinal cord, respectively, of neuropathic rats. Data shown are means S.E.M. of the percentage of changes in DRG or spinal cord ipsilateral to SNL, SNTx, and CCI compared with that in contralateral sides (chosen as 100%), or in DB and VIN rats compared with that in control rats (chosen as 100%). The values in the parentheses indicate the number of independent animals for each group. The asterisks indicate significant changes compared with the values from sham/control animals (, p 0.05; and, p 0.001) as determined by unpaired two-tailed Student s t test. TABLE 1 Summarized data of allodynia, gabapentin sensitivity, and calcium channel 2-1 subunit expression in neuropathic pain models Western blot data were obtained from tissue collected at time points when behavioral pharmacology data were collected as indicated in Fig. 4. The number of plus signs in each column represents the relative degree of significant 2-1 subunit up-regulation compared within DRG or spinal cord samples only; Minus sign indicates no significant change. Neuropathic Models Allodynia Gabapentin Sensitivity 1 Calcium Channel 2-1 Subunit DRG Spinal Cord SNL Yes Yes SNTx Yes Yes CCI Yes Yes DB Yes Yes VIN Yes No Fig. 3. Time-dependent changes of DRG 2-1 subunit expression in nerve-ligated rats. Frozen DRG collected from rats with SNL and CCI neuropathies at the designated times were extracted and the 2-1 subunit levels were examined with Western blot analyses as described. Data are presented as percentages of 2-1 subunit levels in DRG ipsilateral to the nerve injuries compared with that in contralateral DRG, chosen as 100% and reported as means S.E.M. from independent animals as indicated in the parentheses. The asterisks indicate significant changes compared with the control values (, p 0.05;, p 0.01; and, p 0.001) determined by unpaired two-tailed Student s t test. mal models tested (Fig. 4, A D) except in the vincristinetreated animals (Fig. 4E). The antiallodynic effects of the drug were evident as early as 15 to 30 min after drug administration in some models and a complete reversal of the allodynic states was observed about 60 to 90 min after the treatment in all the models sensitive to gabapentin treatment. This antiallodynic efficacy of intraperitoneal gabapentin was similar to that reported in the SNL model (Hunter et al., 1997; Abdi et al., 1998). To test whether the insensitivity of VIN animals to the gabapentin treatment was due to inadequate dosing, we treated VIN rats with 100 and 300 mg/kg intraperitoneal gabapentin and failed to see an allodynia reversal in these animals. We observed mild sedation in animals 30 min after the treatment with 300 mg/kg gabapentin, consistent with reported findings from Hunter et al. (1997). These data are summarized in Table 1. Discussion Our data indicate that 2-1 subunit expression is upregulated significantly in spinal cord dorsal horn (post-snl and DB) and/or DRG (post-snl, SNTx, and CCI) of selected, but not all, types of rat neuropathic pain models examined, suggesting an injury type-specific regulation of the subunit. In addition, antiallodynic effects of gabapentin were observed only in models with significant spinal cord and/or DRG 2-1 subunit up-regulation, even though tactile allodynia developed in all examined neuropathic pain models. This supports the hypothesis that elevation of the 2-1 subunit may underlie the antiallodynic action of gabapentin. However, it also seems that not all allodynic states share a common mechanism involving the 2-1 subunit. Our previous studies led us to speculate that injury-induced DRG 2-1 subunit expression is regulated by factors transported retrogradely from the peripheral nerve because only injuries to the peripheral, but not central, axons caused dramatic up-regulation of the 2-1 subunit (Luo et al., 2001). This could arise either because DRG 2-1 subunit expression is suppressed by factors from innervated tissue and interruption of this negative inhibition would thus in-

5 Injury Type-Specific Ca 2 Channel 2-1 Subunit Regulation 1203 Fig. 4. Effects of gabapentin on tactile allodynia of different neuropathic pain models. Gabapentin (50 mg/kg) (F) or saline (E) was given intraperitoneally to neuropathic rats when maximum tactile allodynia had occurred. In VIN rats (E), 300 mg/kg gabapentin (f) was administered into the same group of rats (n 5) 2 days after the administration of 100 mg/kg gabapentin (Œ). PWTs to von Frey filament stimulation were measured in the injured paws immediately before and at indicated times after the drug administration and reported as means S.E.M. from independent animals in each treatment group as indicated below. In sham-operated animals, the PWT to similar stimulation is between 10 to 15 g (Fig. 1D; Luo et al., 2001). A, rats with SNL for 1 week (n 5). B, rats with SNTx for 1 week (n 6). C, rats with CCI for 2 weeks (n 6). D and E, rats at 4 weeks after the beginning of diabetes induction (n 4) or vincristine treatment (n 5 in each dose group), respectively. The asterisks indicate significant changes compared with saline-treated values (, p 0.05;, p 0.01; and, p 0.001) determined by unpaired two-tailed Student s t test. duce DRG 2 subunit up-regulation or because nerve injury factors generated at the injury site activate 2-1 subunit expression. In the present studies, we found that the magnitude of DRG 2-1 subunit expression in rats with mechanical injuries to peripheral nerves varied with the type of lesion. Some important differences in each of the three models could account for this distinction. The SNL model caused a greater induction than SNTx, despite both injuries being performed at a similar site and equally restricting any putative targetderived inhibitory factors. This would suggest that factors related to the injury site regulate DRG 2-1 subunit expression. The smallest induction of DRG 2-1 subunit was seen after CCI at all the time points examined (Fig. 3), in which the injury is performed more distally in the sciatic nerve. This indicates that the weakest induction by CCI on DRG 2-1 expression at early time points (for example, 1 week post-cci as shown in Figs. 1A and 2A) is not due to lacking of injury factors that would require more time to reach DRG. Because CCI often results in fewer number of damaged DRG neurons and leaves some intact axons that may continue to retrogradely transport target-derived factors from the periphery (Shubayev and Myers, 2001), our data suggest that DRG 2-1 subunit expression after mechanical injury is likely linked to the number of damaged DRG neurons, or determined by a balance between supply of target-derived inhibitory and injury site-derived stimulatory factors, or both. In contrast to mechanical nerve injury, neither DB nor VIN neuropathy altered expression of the 2-1 subunit in the DRG. Others have recently reported increased mrna levels for the 2-1 subunit in the DRG of diabetic rats (Yusaf et al., 2001a), but in the present studies, any increase in mrna expression did not result in a detectable increase of the protein. Although both DB and VIN have been shown to impede retrograde axonal transport (Jakobsen et al., 1981; Macfarlane et al., 1997), there is neither complete loss of retrograde transport mechanisms nor a specific lesion site in the nerve in either model. Thus, restriction of retrograde axonal transport alone is not sufficient to induce changes in DRG 2-1 subunit expression. The pattern of 2-1 subunit expression in the spinal cord of nerve-injured rats did not correlate with that seen in the DRG, with induction of protein being apparent in the SNL, but not SNTx and CCI, mechanical injury model and in DB rats. This distinction may reflect recent findings that the DRG 2-1 subunit differs in structure from the spinal cord 2-1 subunit (Luo, 2000) and thus they may be regulated by different mechanisms. Our Western blot studies do not allow us to determine the cell type(s) within the spinal cord in which this induction takes place, and immunocytochemical investigations are clearly required before conclusions regarding the mechanisms of spinal 2-1 subunit regulation can be formed. It is now appreciated that neuropathic pain encompasses a complex series of phenomena that are unlikely to be ascribed to a single etiological mechanism. Indeed, our findings suggest that 2-1 subunit up-regulation is not a molecular change that uniformly characterizes the neuropathic pain states in all the models. There is some precedence for the differential regulation of a given receptor after different nerve injuries. For example, SNL and peripheral axotomy down-regulate -opioid receptors in the spinal cord and DRG (Goff et al., 1998; Zhang et al., 1998), whereas CCI causes their up-regulation (Goff et al., 1998). This complexity is further illustrated by findings that susceptibility to spinal nerve ligation-induced tactile allodynia is animal strain-dependent (Okuse et al., 1997; Mogil et al., 1999; Luo et al., 2001). Interestingly, vincristine-induced allodynia in Harlan rats is less sensitive to treatment with gabapentin (Fig. 4E) than that in Holtzman rats to treatment with pregabalin (Nozaki-Taguchi et al., 2001), a similar but more potent antiallodynic drug (Field et al., 1999). It seems that the gabapentin insensitivity in our VIN rats is not due to inadequate dose of the drug because both drugs have similar binding affinities to the 2-1 subunit (Suman-Chauhan et al., 1993) and the difference in drug doses between our study (up to 300 mg/kg gabapentin i.p.) and another study (80 mg/kg pregabalin i.p.; Nozaki-Taguchi et al., 2001) exceeds the difference in antiallodynic potencies of these drugs in vivo (Field et al., 1999). It is likely that rat strain-related factors may contribute to this discrepancy. This strain-dependent discrepancy in drug efficacy also occurred in cyclooxygenase-inhibitor treatment in rats with inflammatory pain (C. Svensson, manuscript in preparation) and -opioid antag-

6 1204 Luo et al. onist treatment in mice with acute, thermal nociception (Mogil et al., 1997). Even though it was not proven, it was less likely that altered pharmacokinetics of gabapentin accounted for the gabapentin insensitivity in VIN rats because the antiallodynic effects of gabapentin in other models, including the DB model, occurred quickly after intraperitoneal administration. This suggests that the effective plasma concentration of the drug is reached rapidly after intraperitoneal injection, presumably due to the facts that gabapentin is highly soluble, not metabolized, and not bound to plasma proteins (The U.S. Gabapentin Study Group 5, 1993). Thus, we did not anticipate that VIN treatment would diminish the rapid distribution of the drug, especially at a dose that was 6-fold of the effective dose seen in other models. Although increased expression of the 2-1 subunit is not a common finding to all nerve injury models that exhibit tactile allodynia, it is possible that this induction does contribute to allodynia in the models in which it occurs. This association is supported by our observation that models that showed induction of the 2-1 subunit in either the DRG or spinal cord also exhibited tactile allodynia that could be alleviated by gabapentin. Gabapentin has been reported to bind to the 2-1 subunit in vitro and this could represent the antiallodynic mechanism, assuming that increased 2-1 subunit levels contribute to allodynia and gabapentin also binds to the 2-1 subunit in vivo. Thus, it is possible that elevated 2-1 subunit undergoes redistribution to the central axons and/or injured primary afferents and participates in the generation and maintenance of spontaneous ectopic discharge, either through altered calcium channels or an unknown mechanism. This hypothesis is supported by findings that a redistribution of tetrodotoxin-resistant sodium channel PN3 occurs after CCI (Novakovic et al., 1998), and a similar redistribution of calcium channels is implied because application of N-type calcium channel blockers to the site of CCI can suppress mechanical allodynia (Xiao and Bennett, 1995). The involvement of N-type calcium channel in spinal nerve ligation-induced allodynia was demonstrated in a recent study showing that nerve injuryinduced allodynia was suppressed in mice lacking the N-type specific, channel forming 1 B subunit (Saegusa et al., 2001). Alternatively, increased 2-1 subunit levels could contribute to altered excitability of sensory neurons and other cell types in the sensory pathway that can be stabilized by gabapentin. This is supported by recent findings that gabapentin s antihyperalgesic action depends on the state of target cells. It has been shown that gabapentin inhibits excitatory postsynaptic currents in spinal dorsal horn neurons from hyperalgesic, but not control, animals (Patel et al., 2000). In addition, gabapentin inhibits substance P facilitation in K - evoked release, but not direct K -evoked release, of glutamate from rat caudal trigeminal nucleus (Maneuf et al., 2001). Finally, gabapentin s actions on N-methyl-D-aspartate receptors of spinal dorsal horn neurons require elevated intracellular protein kinase C levels, a state seen in inflamed, but not normal, spinal cord tissue (Gu and Huang, 2001). In combination with the hypothesis that gabapentin may act on other cellular components in addition to calcium channels (Taylor et al., 1998), our data suggest that distinct neuroplasticities in different neuropathies may underlie the complexity of gabapentin s antiallodynic actions. It is possible that gabapentin may interact with different components that may or may not include calcium channel 2-1 subunit. In either event, more studies are required to unravel the mechanism of gabapentin s antiallodynia actions in neuropathic pain models. References Abdi S, Lee DH, and Chung JM (1998) The anti-allodynic effects of amitriptyline, gabapentin and lidocaine in a rat model of neuropathic pain. Anesth Analg 87: Bennett GJ and Xie YK (1988) A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33: Brust PF, Simerson S, McCue AF, Deal CR, Schoonmaker S, Williams ME, Veliçelebi G, Johnson EC, Harpold MM, and Ellis SB (1993) Human neuronal voltagedependent calcium channels: studies on subunit structure and role in channel assembly. Neuropharmacology 32: Chaplan SR, Bach FW, Pogrel JW, Chung JM, and Yaksh TL (1994) Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53: De Jongh KS, Warner C, and Catterall WA (1990) Subunits of purified calcium channels. Alpha 2 and delta are encoded by the same gene. J Biol Chem 265: Dissanayake VU, Gee NS, Brown JP, and Woodruff GN (1997) Spermine modulation of specific [ 3 H]-gabapentin binding to the detergent-solubilized porcine cerebral cortex alpha 2 delta calcium channel subunit. Br J Pharmacol 120: Dixon WJ (1980) Efficient analysis of experimental observations. Annu Rev Pharmacol Toxicol 20: Field MJ, McCleary S, Hughes J, and Singh L (1999) Gabapentin and pregabalin, but not morphine and amitriptyline, block both static and dynamic components of mechanical allodynia induced by streptozocin in the rat. Pain 80: Goff JR, Burkey AR, Goff DJ, and Jasmin L (1998) Reorganization of the spinal dorsal horn in models of chronic pain: correlation with behaviour. Neuroscience 82: Gu Y and Huang L-YM (2001) Gabapentin actions on N-methyl-D-aspartate receptor channels are protein kinase C-dependent. Pain 93: Gurnett CA, De Waard M, and Campbell KP (1996) Dual function of the voltagedependent Ca 2 channel alpha 2 delta subunit in current stimulation and subunit interaction. Neuron 16: Hunter JC, Gogas KR, Hedley LR, Jacobson LO, Kassotakis L, Thompson J, and Fontana DJ (1997) The effect of novel anti-epileptic drugs in rat experimental models of acute and chronic pain. Eur J Pharmacol 324: Hwang JH and Yaksh TL (1997) Effect of subarachnoid gabapentin on tactile-evoked allodynia in a surgically induced neuropathic pain model in the rat. Reg Anesth 22: Jakobsen J, Brimijoin S, Skau K, Sidenius P, and Wells D (1981) Retrograde axonal transport of transmitter enzymes, fucose-labeled protein and nerve growth factor in streptozotocin-diabetic rats. Diabetes 30: Jay SD, Sharp AH, Kahl SD, Vedvick TS, Harpold MM, and Campbell KP (1991) Structural characterization of the dihydropyridine-sensitive calcium channel alpha 2-subunit and the associated delta peptides. J Biol Chem 266: Kim SH and Chung JM (1992) An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 50: Klugbauer N, Lacinova L, Marais E, Hobom M, and Hofmann F (1999) Molecular diversity of the calcium channel 2 subunit. J Neurosci 19: Laird MA and Gidal BE (2000) Use of gabapentin in the treatment of neuropathic pain. Ann Pharmacother 34: Luo ZD (2000) Rat dorsal root ganglia express distinctive forms of the alpha2 calcium channel subunit. Neuroreport 11: Luo ZD, Chaplan SR, Higuera ES, Sorkin LS, Stauderman KA, Williams ME, and Yaksh TL (2001) Upregulation of dorsal root ganglion (alpha)2(delta) calcium channel subunit and its correlation with allodynia in spinal nerve-injured rats. J Neurosci 21: Macfarlane BV, Wright A, and Benson HA (1997) Reversible blockade of retrograde axonal transport in the rat sciatic nerve by vincristine. J Pharm Pharmacol 49: Maneuf YP, Hughes J, and McKnight AT (2001) Gabapentin inhibits the substance P-facilitated K -evoked release of [ 3 H]glutamate from rat caudal trigeminal nucleus slices. Pain 93: Marais E, Klugbauer N, and Hofmann F (2001) Calcium channel 2 subunitsstructure and gabapentin binding. Mol Pharmacol 59: Mogil JS, Richards SP, O Toole LA, Helms ML, Mitchell SR, and Belknap JK (1997) Genetic sensitivity to hot-plate nociception in DBA/2J and C57BL/6J inbred mouse strains: possible sex-specific mediation by delta-2-opioid receptors. Pain 70: Mogil JS, Wilson SG, Bon K, Lee SE, Chung K, Raber P, Pieper JO, Hain HS, Belknap JK, Hubert L, et al. (1999) Heritability of nociception I: responses of 11 inbred mouse strains on 12 measures of nociception. Pain 80: Mori Y, Friedrich T, Kim MS, Mikami A, Nakai J, Ruth P, Bosse E, Hofmann F, Flockerzi V, Furuichi T, et al. (1991) Primary structure and functional expression from complementary DNA of a brain calcium channel. Nature (Lond) 350: Novakovic SD, Tzoumaka E, McGivern JG, Haraguchi M, Sangameswaran L, Gogas KR, Eglen RM, and Hunter JC (1998) Distribution of the tetrodotoxin-resistant sodium channel PN3 in rat sensory neurons in normal and neuropathic conditions. J Neurosci 18: Nozaki-Taguchi N, Chaplan SR, Higuera ES, Ajakwe RC, and Yaksh TL (2001) Vincristine-induced allodynia in the rat. Pain 93: Okuse K, Chaplan SR, McMahon SB, Luo ZD, Calcutt NA, Scott BP, Akopian AN, and Wood JN (1997) Regulation of expression of the sensory neuron-specific

7 Injury Type-Specific Ca 2 Channel 2-1 Subunit Regulation 1205 sodium channel SNS in inflammatory and neuropathic pain. Mol Cell Neurosci 10: Patel MK, Gonzalez MI, Bramwell S, Pinnock RD, and Lee K (2000) Gabapentin inhibits excitatory synaptic transmission in the hyperalgesic spinal cord. Br J Pharmacol 130: Saegusa H, Kurihara T, Zong S, Kazuno AA, Matsuda Y, Nonaka T, Han W, Toriyama H, and Tanabe T (2001) Suppression of inflammatory and neuropathic pain symptoms in mice lacking the N-type Ca 2 channel. EMBO J 20: Shubayev VI and Myers RR (2001) Axonal transport of TNF- in painful neuropathy: distribution of ligand tracer and TNF receptors. J Neuroimmunol 114: Suman-Chauhan N, Webdale L, Hill DR, and Woodruff GN (1993) Characterisation of [ 3 H]gabapentin binding to a novel site in rat brain: homogenate binding studies. Eur J Pharmacol 244: Taylor CP, Gee NS, Su TZ, Kocsis JD, Welty DF, Brown JP, Dooley DJ, Boden P, and Singh L (1998) A summary of mechanistic hypotheses of gabapentin pharmacology. Epilepsy Res 29: The U.S. Gabapentin Study Group No. 5 (1993) Gabapentin as add-on therapy in refractory partial epilepsy: a double-blind, placebo-controlled, parallel-group study. Neurology 43: Williams ME, Feldman DH, McCue AF, Brenner R, Velicelebi G, Ellis SB, and Harpold MM (1992) Structure and functional expression of alpha 1, alpha 2 and beta subunits of a novel human neuronal calcium channel subtype. Neuron 8: Xiao WH and Bennett GJ (1995) Synthetic omega-conopeptides applied to the site of nerve injury suppress neuropathic pains in rats. J Pharmacol Exp Ther 274: Yusaf SP, Goodman J, Gonzalez IM, Bramwell S, Pinnock RD, Dixon AK, and Lee K (2001a) Streptozocin-induced neuropathy is associated with altered expression of voltage-gated calcium channel subunit mrnas in rat dorsal root ganglion neurons. Biochem Biophy Res Commun 289: Yusaf SP, Goodman J, Pinnock RD, Dixon AK, and Lee K (2001b) Expression of voltage-gated calcium channel subunits in rat dorsal root ganglion neurons. Neurosci Lett 311: Zhang X, Bao L, Shi TJ, Ju G, Elde R, and Hökfelt T (1998) Down-regulation of -opioid receptors in rat and monkey dorsal root ganglion neurons and spinal cord after peripheral axotomy. Neuroscience 82: Address correspondence to: Dr. Z. David Luo, Department of Anesthesiology, University of California, San Diego, 9500 Gilman Dr., La Jolla, CA zluo@ucsd.edu